Interaction of mithramycin with metal ions and DNA.
The interaction of mithramycin with metal ions has been studied by absorbance and fluorescence spectroscopy. Magnesium shifts the drug absorbance spectrum to longer wavelengths and displays a weak binding constant (Kd = 1mM); no interaction with calcium was detected. The drug requires magnesium for binding to DNA and this is characterised by small additional hypochromic and bathochromic changes. Mithramycin does not bind to DNA in the presence of calcium. With 10mM magnesium the drug binds to DNA with an association constant of 9.2 x 10(4) M-1. The inability of calcium to substitute for magnesium has been confirmed by 'footprinting' experiments using both DNase I and hydroxyl radicals.
Cons
B M
BM
Dept. Physiology & Pharmacology, University of Southampton, U.K.
Fox
K R
KR
D001483:Base Sequence; D001665:Binding Sites; D002118:Calcium; D004247:DNA; D003850:Deoxyribonuclease I; D004347:Drug Interactions; D008274:Magnesium; D008670:Metals; D008969:Molecular Sequence Data; D009710:Nucleotide Mapping; D008926:Plicamycin; D013050:Spectrometry, Fluorescence; D013054:Spectrophotometry, Atomic
D008670:Metals; D004247:DNA; D003850:Deoxyribonuclease I; D008274:Magnesium; D008926:Plicamycin; D002118:Calcium